News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
779,137 Results
Type
Article (69620)
Company Profile (337)
Press Release (709168)
Multimedia
Podcasts (220)
Webinars (32)
Section
Business (229862)
Career Advice (3841)
Deals (36024)
Drug Delivery (174)
Drug Development (86164)
Employer Resources (206)
FDA (17523)
Job Trends (15913)
News (350302)
Policy (35423)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (3)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3025)
Academic (1)
Accelerated approval (59)
ADA (49)
Adcomms (42)
Allergies (211)
Alliances (50745)
ALS (242)
Alzheimer's disease (2008)
Antibody-drug conjugate (ADC) (584)
Approvals (17920)
Artificial intelligence (845)
ASCO (344)
Autoimmune disease (380)
Automation (67)
Bankruptcy (362)
Best Places to Work (12346)
BIO (79)
BIOSECURE Act (23)
Biosimilars (259)
Biotechnology (239)
Bladder cancer (214)
Brain cancer (85)
Breast cancer (857)
Cancer (6744)
Cardiovascular disease (571)
Career advice (3309)
Career pathing (53)
CAR-T (395)
CDC (76)
Celiac Disease (3)
Cell therapy (1094)
Cervical cancer (57)
Clinical research (74953)
Collaboration (2445)
Commercialization (1)
Company closure (8)
Compensation (1520)
Complete response letters (111)
COVID-19 (3026)
CRISPR (130)
C-suite (1350)
Cystic fibrosis (170)
Data (8969)
Decentralized trials (3)
Denatured (80)
Depression (204)
Dermatology (105)
Diabetes (721)
Diagnostics (7437)
Digital health (68)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (419)
Drug pricing (246)
Drug shortages (39)
Duchenne muscular dystrophy (332)
Earnings (83470)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (127029)
Executive appointments (1206)
FDA (21759)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (2001)
Gene editing (281)
Generative AI (78)
Gene therapy (867)
GLP-1 (1289)
Government (5448)
Grass and pollen (8)
Guidances (425)
Healthcare (20897)
Hematology (191)
HIV (98)
Huntington's disease (71)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (119)
Immunology and inflammation (364)
Immuno-oncology (122)
Indications (225)
Infectious disease (3432)
Inflammatory bowel disease (246)
Inflation Reduction Act (17)
Influenza (152)
Intellectual property (331)
Interviews (752)
IPO (17026)
IRA (61)
Job creations (3890)
Job search strategy (2653)
JPM (72)
Kidney cancer (23)
Labor market (125)
Layoffs (668)
Leadership (54)
Legal (8417)
Liver cancer (111)
Longevity (37)
Lung cancer (893)
Lymphoma (491)
Machine learning (68)
Management (68)
Manufacturing (1271)
Marketing (5)
MASH (230)
Medical affairs (1)
Medical device (14761)
Medtech (14951)
Mergers & acquisitions (20372)
Metabolic disorders (1864)
mRNA (280)
Multiple sclerosis (212)
NASH (24)
Neurodegenerative disease (534)
Neuropsychiatric disorders (131)
Neuroscience (3816)
Neurotech (2)
NextGen: Class of 2026 (7439)
Non-profit (5079)
Now hiring (71)
Obesity (890)
Opinion (381)
Ovarian cancer (250)
Pain (292)
Pancreatic cancer (373)
Parkinson's disease (428)
Partnered (38)
Patents (676)
Patient recruitment (824)
Peanut (72)
People (61625)
Pharmaceutical (56)
Pharmacy benefit managers (38)
Phase 1 (23381)
Phase 2 (32827)
Phase 3 (24691)
Pipeline (10338)
Policy (403)
Postmarket research (2818)
Preclinical (10060)
Press Release (71)
Prostate cancer (356)
Psychedelics (75)
Radiopharmaceuticals (380)
Rare diseases (1339)
Real estate (6260)
Recruiting (82)
Regulatory (27928)
Reports (74)
Research institute (2734)
Resumes & cover letters (596)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (344)
Series B (251)
Service/supplier (7)
Sickle cell disease (133)
Special edition (33)
Spinal muscular atrophy (188)
Sponsored (55)
Startups (3835)
State (2)
Stomach cancer (21)
Supply chain (147)
Tariffs (103)
The Weekly (137)
Vaccines (1319)
Venture capital (141)
Weight loss (604)
Women's health (145)
Worklife (25)
Date
Last 7 days (426)
Last 30 days (1927)
Last 365 days (32141)
2026 (17741)
2025 (32000)
2024 (36938)
2023 (41831)
2022 (53133)
2021 (57914)
2020 (56710)
2019 (50349)
2018 (38265)
2017 (35338)
2016 (35245)
2015 (40532)
2014 (33128)
2013 (30702)
2012 (30189)
2011 (30562)
2010 (28363)
Location
Africa (1110)
Alabama (102)
Alaska (7)
Arizona (334)
Arkansas (16)
Asia (46385)
Australia (8123)
California (14372)
Canada (4071)
China (1641)
Colorado (613)
Connecticut (645)
Delaware (438)
Europe (107290)
Florida (2185)
Georgia (466)
Hawaii (3)
Idaho (67)
Illinois (1226)
India (106)
Indiana (639)
Iowa (25)
Japan (617)
Kansas (140)
Kentucky (55)
Louisiana (62)
Maine (91)
Maryland (1727)
Massachusetts (10543)
Michigan (416)
Minnesota (788)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (156)
New Hampshire (91)
New Jersey (3829)
New Mexico (35)
New York (3817)
North Carolina (1903)
North Dakota (10)
Northern California (7201)
Ohio (453)
Oklahoma (27)
Oregon (44)
Pennsylvania (2836)
Puerto Rico (33)
Rhode Island (53)
South America (1444)
South Carolina (89)
South Dakota (2)
Southern California (5724)
Tennessee (228)
Texas (2337)
United States (51354)
Utah (433)
Vermont (2)
Virginia (365)
Washington D.C. (85)
Washington State (1180)
West Virginia (4)
Wisconsin (154)
Wyoming (2)
779,137 Results for "be the match biotherapies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Zymeworks adds lung disease drug, royalty deals in nearly $1B pick up of Theravance
Zymeworks announced a new plan to become a royalty-driven company last year, making Theravance a perfect match.
June 29, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Resolution Therapeutics congratulates University of Edinburgh on positive 4-year MATCH trial data on RMT in liver cirrhosis
May 26, 2026
·
4 min read
Press Releases
Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting
July 2, 2026
·
3 min read
Press Releases
MultiValent Biotherapies Launches with $27 Million Series A Financing to Advance Development of Targeted Prostate Cancer Drug Conjugate
June 16, 2026
·
3 min read
Press Releases
Blood Cancer Treatment Allows Hard-to-Match Kidney Failure Patients to Receive a Compatible Kidney Transplant
June 4, 2026
·
7 min read
Immunology and inflammation
Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly’s Ebglyss
Apogee’s pipeline in a product drug zumilokibart achieved significant disease clearance in a mid-stage atopic dermatitis trial, but investors were miffed by a royalty financing deal with Blackstone.
May 27, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
GenSight Biologics Announces Publication on Matching-Adjusted Indirect Comparison of Leber Hereditary Optic Neuropathy Treatments
May 11, 2026
·
3 min read
Press Releases
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
Strengthens iSpecimen’s next-generation marketplace platform
March 13, 2026
·
4 min read
Press Releases
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
May 7, 2026
·
3 min read
Rare diseases
As New Hereditary Angioedema Drugs Flood the Market, Will Uptake Match Innovation?
This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question whether they will be enough to net their developers a significant share of the entrenched market.
December 1, 2025
·
5 min read
·
Ben Hargreaves
1 of 77,914
Next
